282 related articles for article (PubMed ID: 25465415)
1. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
[TBL] [Abstract][Full Text] [Related]
2. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
[TBL] [Abstract][Full Text] [Related]
5. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
Girardi DM; Silva ACB; Rêgo JFM; Coudry RA; Riechelmann RP
Cancer Treat Rev; 2017 May; 56():28-35. PubMed ID: 28456055
[TBL] [Abstract][Full Text] [Related]
6. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
7. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
Kim KJ; Lee TH; Cho NY; Yang HK; Kim WH; Kang GH
Hum Pathol; 2013 Jun; 44(6):1055-64. PubMed ID: 23266441
[TBL] [Abstract][Full Text] [Related]
8. Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.
Scardoni M; Vittoria E; Volante M; Rusev B; Bersani S; Mafficini A; Gottardi M; Giandomenico V; Malleo G; Butturini G; Cingarlini S; Fassan M; Scarpa A
Neuroendocrinology; 2014; 100(4):310-6. PubMed ID: 25342539
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancers with the Uncommon Findings of KRAS Mutation and Microsatellite Instability.
Zauber P; Marotta S; Sabbath-Solitare M
Cytogenet Genome Res; 2015; 146(4):261-7. PubMed ID: 26523369
[TBL] [Abstract][Full Text] [Related]
11. Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
Vanoli A; Perfetti V; Furlan D; Neri G; Viglio A; Sessa F; Martino M; Di Sabatino A; Solcia E; La Rosa S
Endocr Pathol; 2020 Dec; 31(4):411-417. PubMed ID: 32388775
[TBL] [Abstract][Full Text] [Related]
12. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
14. Should immunohistochemical expression of mismatch repair (MMR) proteins and microsatellite instability (MSI) analysis be routinely performed for poorly differentiated colorectal neuroendocrine carcinomas?
Luong TV; Nisa Z; Watkins J; Hayes AR
Endocrinol Diabetes Metab Case Rep; 2020 Jul; 2020():. PubMed ID: 32729847
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
Gologan A; Sepulveda AR
Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
[TBL] [Abstract][Full Text] [Related]
16. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
Modica I; Soslow RA; Black D; Tornos C; Kauff N; Shia J
Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459
[TBL] [Abstract][Full Text] [Related]
17. Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms.
Elvebakken H; Hjortland GO; Garresori H; Andresen PA; Janssen EAM; Vintermyr OK; Lothe IMB; Sorbye H
J Neuroendocrinol; 2023 Apr; 35(4):e13256. PubMed ID: 37017614
[TBL] [Abstract][Full Text] [Related]
18. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
[TBL] [Abstract][Full Text] [Related]
20. Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis.
Milione M; Maisonneuve P; Pellegrinelli A; Grillo F; Albarello L; Spaggiari P; Vanoli A; Tagliabue G; Pisa E; Messerini L; Centonze G; Inzani F; Scarpa A; Papotti M; Volante M; Sessa F; Fazio N; Pruneri G; Rindi G; Solcia E; La Rosa S; Capella C
Endocr Relat Cancer; 2018 May; 25(5):583-593. PubMed ID: 29592868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]